14|0|Public
50|$|Sclareol {{is used as}} a {{fragrance}} in {{cosmetics and}} perfumes and as flavoring in food. Sclareol and other similar substances may be prepared from <b>sclareolide.</b>|$|E
5000|$|<b>Sclareolide</b> is a {{sesquiterpene}} lactone {{natural product}} derived from various plant sources including Salvia sclarea, Salvia yosgadensis, and cigar tobacco. [...] It {{is a close}} analog of sclareol, a plant antifungal compound.|$|E
40|$|The title {{compound}} (common name: sclaral), C 16 H 28 O 2, is a <b>sclareolide</b> derivative, {{which was}} synthesized from <b>sclareolide</b> itself. In the molecule, the two six-membered rings, A and B, of the labdane skeleton adopt chair conformations and the five-membered O-containing heterocyclic ring C displays an envelope conformation, with the methine C atom of the fused C—C bond as the flap. In the crystal, molecules are linked by O—H [...] . O hydrogen bonds, forming chains propagating along [100]...|$|E
40|$|ATP binding {{cassette}} (ABC) transporters, {{which are}} found in all species, are known mainly {{for their ability to}} confer drug resistance. To date, most of the ABC transporters characterized in plants have been localized in the vacuolar membrane and are considered {{to be involved in the}} intracellular sequestration of cytotoxins. Working on the assumption that certain ABC transporters might be involved in defense metabolite secretion and their expression might be regulated by the concentration of these metabolites, we treated a Nicotiana plumbaginifolia cell culture with <b>sclareolide,</b> a close analog of sclareol, an antifungal diterpene produced at the leaf surface of Nicotiana spp; this resulted in the appearance of a 160 -kD plasma membrane protein, which was partially sequenced. The corresponding cDNA (NpABC 1) was cloned and shown to encode an ABC transporter. In vitro and in situ immunodetection showed NpABC 1 to be localized in the plasma membrane. Under normal conditions, expression was found in the leaf epidermis. In cell culture and in leaf tissues, NpABC 1 expression was strongly enhanced by <b>sclareolide</b> and sclareol. In parallel with NpABC 1 induction, cells acquired the ability to excrete a labeled synthetic <b>sclareolide</b> derivative. These data suggest that NpABC 1 is involved in the secretion of a secondary metabolite that plays a role in plant defense...|$|E
40|$|The title {{compound}} (common name: 3 &# 946;-acetoxy- 8 -epi-sclareolide), C 18 H 28 O 4, is a <b>sclareolide</b> derivative, {{which was}} synthesized from 9 (11) -en- 3 &# 946;-acetoxy- 8 -epi-sclareolide. In the molecular structure, the two six-membered rings display chair conformations and the five-membered ring displays an envelope conformation. Weak intermolecular C&# 8212;H [...] . O hydrogen bonding {{is present in}} the crystal structure...|$|E
40|$|The {{synthesis}} of new nitrogen-containing drimane and homodrimane sesquiterpenoids in cycle B is reported. A {{comparative study of}} the microwave (MW) assisted {{synthesis of}} drimenone versus classical conditions has been done. The drimanic and homodrimanic oximes were prepared {{on the base of}} ketones derived from commercially available <b>sclareolide.</b> The drimanic amine was obtained by reduction of corresponding oxime with LiAlH 4. The structure of novel compounds was confi rmed using IR, 1 H and 13 C NMR analyses...|$|E
40|$|This {{dissertation}} {{describes the}} development of synthesis strategies for the lissoclimide natural product syntheses starting from either <b>sclareolide</b> or geranyl acetate. Chapter 1 focuses on the isolation and biological activity of lissoclimide terpenoid natural products. Previous synthesis efforts from the Vanderwal lab and other groups are described. 	Chapter 2 focuses on the semi-synthesis of chlorolissoclimide, haterumaimide N, and haterumaimide Q from <b>sclareolide.</b> Development of a reliable Evans auxiliary based aldol approach to the hydroxysuccinimide moiety common to all lissoclimide natural products is described. The C–H chlorination of <b>sclareolide</b> is vastly improved {{with the use of}} a new chlorinating protocol co-developed with the Alexanian lab, enabling the first synthesis of chlorolissoclimide in 9 steps and 14 % overall yield. 	Chapter 3 focuses on a fully synthetic route towards the lissoclimides from geranyl acetate featuring an epoxide-initiated bicyclization. This strategy provides access to a readily diversifiable intermediate that is converted to haterumaimide Q and key analogues. A key finding was that the preference for Fürst–Plattner addition of chlorine across an alkene on a rigid decalin system is partially reversed in the presence of a homoallylic trifluoroacetate. The resulting diequatorial dichlorides are found in several of the most potent lissoclimides. 	Chapter 4 focuses on four key biological investigations our syntheses have enabled: (1) the Yusupov group elucidated the biological mode of action via a co-crystal structure of chlorolissoclimide in the E-site of the eukaryotic large ribosomal subunit (2); our synthetic lissoclimide natural products and analogues were screened against several cell lines to determine structure activity relationships (SAR); (3) the structural information was used to computationally rationalize the observed SAR; and (4) these compounds were evaluated for their ability to eradicate several viral infections, including Ebola, exhibiting EC 50 values of 20 nM. 	Chapter 5 focuses on the exploration of 2, 2 -disubstituted epoxide-initiated bicyclizations to access haterumaimide J. A Ti(III) radical cyclization strategy is first explored using several cyclization precursors. Lewis-acid-catalyzed bicyclizations are described for our efforts towards both haterumaimide J and hydroxytotarol...|$|E
40|$|Expression of NpABC 1, a gene {{encoding}} a {{plasma membrane}} ATP binding cassette (ABC) transporter in Nicotiana plumbaginifolia, is induced by sclareol, an antifungal diterpene produced at the leaf surface, {{as well as by}} <b>sclareolide,</b> a close analog. A genomic fragment including the 1282 -bp region upstream of the NpABC 1 transcription start was fused to the reporter beta-glucuronidase (gus) gene and introduced into N. tabacum BY 2 cells for stable transformation. A 25 -fold increase in gus expression was observed when cells were treated with <b>sclareolide</b> and some other terpenes. The combined use of 5 '-deletion promoter analysis, gel mobility shift assays, DNase I footprinting, and site-directed mutagenesis allowed us to identify three cis-elements (sclareol box 1 (SB 1), SB 2, and SB 3) located, respectively, within nucleotides - 827 to - 802, - 278 to - 243, and - 216 to - 190 upstream of the NpABC 1 transcription start. In vivo evaluation of these elements on sclareolide-induced expression showed that mutation of SB 1 reduced expression by twofold, while that of SB 2 had no effect. On the other hand, SB 3 had a marked effect as it completely abolished sclareolide-mediated expression. NpABC 1 -gus expression was not induced by the stress signals, salicylic acid and ethylene, but was mediated, to some extent, by methyl jasmonate, which is known to promote diterpene synthesis...|$|E
40|$|The site {{selectivities}} and stereoselectivities of C-H oxidations of substituted cyclohexanes and trans-decalins by dimethyldioxirane (DMDO) {{were investigated}} computationally with quantum mechanical density functional theory (DFT). The multiconfiguration CASPT 2 method was employed on model systems {{to establish the}} preferred mechanism and transition state geometry. The reaction pathway involving a rebound step is established {{to account for the}} retention of stereochemistry. The oxidation of <b>sclareolide</b> with dioxirane reagents is reported, including the oxidation by the in situ generated tBu-TFDO, a new dioxirane that better discriminates between C-H bonds on the basis of steric effects. The release of 1, 3 -diaxial strain in the transition state contributes to the site selectivity and enhanced equatorial C-H bond reactivity for tertiary C-H bonds, a result of the lowering of distortion energy. In addition to this strain release factor, steric and inductive effects contribute to the rates of C-H oxidation by dioxiranes...|$|E
40|$|A {{new method}} has been {{developed}} that detects significant quantitative differences in the amounts of pyrazines, pyridines, furfurals, carboxylic acids, b-damascenone, <b>sclareolide,</b> and megastigmatrienones in the mainstream smoke {{of a series of}} five commercial cigarettes. This new quantitative method is based on the gas chromatographic-selected ion monitoring-mass spectrometric (GC-SIM-MS) determination of the selected smoke constituents. The accuracy and precision of the approach were well within acceptable parameters with the majority of cases relative standard deviation (RSD) values consistently around 5 %. Sample preparation was simple requiring only the dissolution of the trapped particulate material in a known volume of methanol followed by injection of this clear dark colored solution into the gas chromatograph. This approach represents an advance in the technology in terms of higher sample throughput and less sample workup. Certain products demonstrated consistent trends in concentration of specific chemical classes. The mainstream smoke from a University of Kentucky reference cigarette, 2 R 4 F, was included for reference purposes. These results are applicable in the overall evaluation of the components responsible for the taste associated with cigarette products...|$|E
40|$|Sodium periodate (NaIO 4) {{is shown}} to be a milder and more {{efficient}} terminal oxidant for C–H oxidation with Cp*Ir (Cp* = C 5 Me 5) precatalysts than ceric(IV) ammonium nitrate. Synthetically useful yields, regioselectivities, and functional group tolerance were found for methylene oxidation of substrates bearing a phenyl, ketone, ester, or sulfonate group. Oxidation of the natural products (−) -ambroxide and <b>sclareolide</b> proceeded selectively, and retention of configuration was seen in cis-decalin hydroxylation. At 60 °C, even primary C–H bonds can be activated: whereas methane was overoxidized to CO 2 in 39 % yield without giving partially oxidized products, ethane was transformed into acetic acid in 25 % yield based on total NaIO 4. 18 O labeling was demonstrated in cis-decalin hydroxylation with 18 OH 2 and NaIO 4. A kinetic isotope effect of 3. 0 ± 0. 1 was found in cyclohexane oxidation at 23 °C, suggesting C–H bond cleavage as the rate-limiting step. Competition experiments between C–H and water oxidation show that C–H oxidation of sodium 4 -ethylbenzene sulfonate is favored by 4 orders of magnitude. In operando time-resolved dynamic light scattering and kinetic analysis exclude the involvement of metal oxide nanoparticles and support our previously suggested homogeneous pathway...|$|E
40|$|<b>Sclareolide</b> (1) was {{incubated}} {{with eight}} {{different species of}} filamentous fungi conventionally used for bio-oxidations. Compound 1 was metabolized with Aspergillus niger in medium A to yield 3 -ketosclareolide (2) and 3 &# 946;-hydroxysclareolide (4), while in medium B (containing major number of nutrients with respect to medium A), compounds 2, 4, 3 &# 945;, 6 &# 946;-dihydroxysclareolide (16), 1 -ketosclareolide (17), 3 -keto- 15 -hydroxysclareolide (18) and 3 &# 946;, 15 -dihydroxysclareolide (19) were obtained. The biotransformation products 16 - 19 {{were found to be}} new substances. Fermentation of 1 with Cunninghamella blackesleeana using medium A afforded 2 and 4, while using medium B yielded 2, 4, 16 and 17. Compounds 2, 4 and 17 were also obtained with Curvularia lunata. Biotransformation of 1 with Beauveria bassiana yielded 4 in satisfactory yield, with Rhizopus oligosporus and Mucor miehei afforded 2 and 4, while with R. nigricans and Fusarium moliniforme yielded 2, 4 and 16. Cytotoxic evaluation of 1 and the obtained products against selected human cancer cell lines (U 251, PC- 3, K 562, HCT- 15, MCF- 7 and SKUL- 1) indicated that 16 (3 a, 6 b-dihydroxysclareolide) displayed moderate cytotoxic (IC 50 < 100 mM) against U 251, PC- 3, HCT- 15 and MCF- 7...|$|E
40|$|This Ph. D. {{dissertation}} {{describes the}} microbial transformation of eight biologically active terpenes and steroidal natural products: (-) -ambrox (56), (+) -sclareolide (61), (+) isolongifolen- 4 -one (77), (-) -isolongifolol (78), norethisterone (96), 17 a-ethynylestradiol (97), (+) -androsta-l, 4 -dien- 3, 17 -dione (103) and (+) -adrenosterone (110). These compounds {{were subjected to}} fungal transformations using a standard two-stage fermentation technique, leading to the isolation of 38 metabolites, of which 16 were new. Incubation of (-) -ambrox (55) {{with a number of}} fungi afforded, 3 -oxoambrox (60), <b>sclareolide</b> (61), 3 B-hydroxyambrox (62), la-hydroxyambrox (63), la,lladihydroxyambrox (64), la, 6 a-dihydroxyambrox (65), 3 B, 6 B-dihydroxyambrox (66), tetra-nor- 8, 12 -dihydroxylabdane(67) andla, 6 a,lla-trihydroxyambrox(68). Metabolites 63 - 65 and 68 were found to be new compounds. [Helv. Chim. Acta, 2004 (accepted) ] (+) -Sclareolide (61) yielded 3 -oxosclareolide (69), 3 J 3 -hydroxysclareolide (70), 2 a. hydroxysclareolide (71), 2 a., 3 B -dihydroxysclareolide (72), 1 a., 3 B-dihydroxysclareolide (73), and 3 B-hydroxyepisclareolide (74) on incubation with Cunninghamella elegans. Compounds 71, 72 and 74 were found to be new. The transformed metabolites of sc 1 areolide i. e. 69 - 74, showed significant phytotoxicity compared to the parent compound. [Helv. Chim. Acta, 2004 (accepted) ] (+) -Isolongifolen- 4 -one (77) on fermentation with various fungal strains afforded mainly the new hydroxylated metabolites: (7 R) - 12 -hydroxyisolongifolen- 4 -one (79), (7 S- 12 hydroxyisolongifolen- 4 -one (80), (11 S- 9 -hydroxyisolongifolen- 4 -one (81), (9 S- 9 hydroxyisolongifolen- 4 -one (82) and (l 0 R) - 9 -hydroxyisolongifolen- 4 -one (83). The metabolites and their chemical derivatives showed potent tyrosinase inhibitory activity. [He/v. Chim. Acta, 2004, 86, 3450] The microbial transformation of (-) -isolongifolol (78) yielded three new metabolites: 10 oxoisolongifolol (93), 10 a. -hydroxyisolongifolol (94) and 9 a. -hydroxyisolongifolol (95). Compound 94 showed potent activity in butyrylcholinesterase assay. Incubation of norethisterone (96) with Cephalosporium aphidicola afforded an oxidized metabolite 17 a-ethynylestradiol (97). Further incubation of compound 97 yielded six oxidative metabolites: 19 -nor- 17 a-pregna-I, 3, 5 (I 0) -trien- 20 -yne- 3, 4, 17 B. triol (98), 19 nor- 17 a-pregna-I, 3, 5 (l 0) -trien- 20 -yne- 3, 7 a, 17 P. triol (99), 19 -nor- 17 a-pregna-I, 3, 5 (1 0) -trien- 20 -yne- 3, II a, 17 B. triol (100), I 9 -nor- 17 a-pregna-l, 3, 5 (10) -trien- 20 -yne 3, 6 p,I 7 B. triol (101) and 19 -nor- 17 a-pregna-I, 3, 5 (l 0) -trien- 20 -yne- 3, 17 B. diol- 6 P. methoxy (102). Compound 102 was found to be a new one. [Z. Naturforsch., 2004, 59 b, 323] (+) _Androsta- 1, 4 -dien- 3, 17 -dione (103) was converted into six biotransformed products: androst- 4 -en- 3, 17 -dione (104), 17 B_hydroxyandrosta-l, 4 -dien- 3 -one (105), 11 ahydroxyandrosta-l, 4 -dien- 3, 17 -dione (106), 11 a-hydroxyandrost- 4 -en- 3, 17 -dione (107), 17 p, 11 a-dihydroxyandrost- 4 -en- 3 -one (108) and 17 B, 11 a-dihydroxyandrosta-l, 4 -dien- 3 one (109. [Nat. Prod. Lett., 2003, 16, 345] (+) -Adrenosterone (110) yielded three transformed products: 17 (3 -hydroxyandrost- 4 -en 3, 11, 17 -trione (111), androsta- 1, 4 -dien- 3, 11, 17 -trione (112) and 17 (3 -hydroxyandrosta 1, 4 -dien- 3, 11 -dione (113). [Nat. Prod Lett., 2003, 16, 417] In addition, chemical investigation on a marine fungus Aspergillus terreus led to the isolation of a new 131 and five known 132 - 136 metabolites. Compounds 132 and 133 were also isolated as a new source. All metabolites were tested for antifungal and antioxidant activities. [2. Naturforsch., 2004, 59 b, 328] Modem spectroscopic techniques, including two-dimensional NMR, single X-ray diffraction and mass spectrometry, were employed for the structure elucidation of new metabolites...|$|E
40|$|Cyclic terpenoids form a {{large group}} of natural {{products}} with various biological functions. About 60, 000 different cyclic terpenoids have been identified by now, containing scaffolds of ten to more than 30 carbon atoms. Among this huge amount of different cyclic compounds, there are many well-known flavors and fragrances, such as menthol or limonene, compounds which are widely used for pharmaceutical purposes like the antitumor compound Taxol and the anti-malaria agent artemisinin, or common membrane constituents and hormones such as the sterols. All of these natural products are derived from cyclization reactions of few linear precursor molecules catalyzed by terpenoid cyclases. The main focus of the present work rests on one very interesting family of the terpenoid cyclases, the squalene-hopene cyclases (SHCs). Among the over 300 annotated SHCs, most extensive studies had been carried out characterizing the SHC from the thermophilic bacterium Alicyclobacillus acidocaldarius (AacSHC), solving the crystal structure and the complex cyclization mechanism of the C 30 precursor squalene into the pentacyclic products hopene and hopanol. This reaction constitutes one of the most complex reaction mechanisms found in nature, including the stereospecific formation of nine stereocenters and 13 covalent bonds. 13 Besides AacSHC, several SHCs were partially characterized in previous works. Our interest was triggered by the ethanol and sugar tolerant strain Zymomonas mobilis which is {{known as one of the}} most potent hopanoid producers. Zymomonas mobilis contains two genes encoding for SHCs: ZmoSHC 1 and the formerly partially characterized ZmoSHC 2. It could be shown that the SHCs are also capable of cyclizing other linear terpenoids. For example, it was found that truncated squalene analogs were accepted as substrates by AacSHC and also the alcohol homofarnesol could be converted into the corresponding cyclic ether ambroxan. 16 – 19 These results indicate that SHCs represent a promising family for catalysis of very different and complex cyclization reactions. Thus, we decided to investigate the SHCs’ potentials regarding their substrate specificities. In order to characterize the squalene-hopene cyclases ZmoSHC 1 and ZmoSHC 2 and compare them with AacSHC especially regarding their biocatalytic activities towards unnatural substrates, the SHCs were cloned and heterologously expressed in Escherichia coli. Functional expression was confirmed by conversion of the natural substrate squalene. For the direct comparison, a protocol for partial purification of the membrane-anchored SHCs was elaborated and optimized. For this partial purification as well as for the conversion of the hydrophobic substrates in aqueous milieu a suitable detergent had to be selected. ZmoSHC 1 was characterized in more detail, retrieving information about pH- and temperature-dependence of the activity and the biocatalytic stability over a long period of time as well as inhibitory effects. All of the three enzymes were tested with unnatural substrates of C 10 -C 18 carbon chain lengths. A special focus was laid on substrates containing functional groups such as hydroxyl, carboxy- or keto-groups expected to participate in the cyclization reaction, as shown for the hydroxyl-group of homofarnesol. Several of the substrates were accepted and cyclic products were generated. Interestingly, the functional groups were integrated in the final ring closure and to products with new properties were obtained. Homofarnesol conversion yielding the cyclic ether ambroxan, which is known as a expensive and rare flavor compound, was observed as reported in the literature. Also the corresponding carboxylic acid, homofarnesoic acid, could be converted into the cyclic lactone <b>sclareolide.</b> The C 15 tertiary alcohol nerolidol was accepted as substrate and the bicyclic ether caparrapioxide was formed. Lastly, two ketones were accepted as substrates leading to cyclic enol ether products. Within the present work, all of these new products were characterized after preparative biotransformation and product isolation. Not only the facts that these substrates are much shorter than the natural substrate squalene and possess different functional groups which take part in the cyclization reaction and that useful products containing new properties are formed, but also the different activities of the SHCs towards these substrates are remarkable. Thus, it could be shown that ZmoSHC 1 exhibits special biocatalytic properties, as the substrate activity pattern was unexpected. While squalene was converted very poorly, good activity was found towards the reaction of homofarnesol to ambroxan. All of the other substrates were converted in low but significant rates into the corresponding cyclic products. A completely different substrate activity pattern was observed using AacSHC as biocatalyst. Besides very good squalene conversion, much lower activities towards all of the other substrates were found. Using ZmoSHC 2, only very low conversion rates were found for squalene and farnesylacetone and no conversion of any of the other substrates. Based on these observations, it can be concluded that ZmoSHC 1 represents a versatile biocatalyst for complex cyclization reactions, as it shows unexpected substrate activity towards other substrates than squalene. In the present work, these and further detailed results are described. Besides the examination of the SHCs’ activities towards different substrates there were also several mutants created in order to find explanations for the differences between the SHCs regarding their substrate activities. This characterization of the triterpenoid cyclase ZmoSHC 1 and discussion of their special properties leads to new conclusions about the potential of SHCs to serve as potent biocatalysts for new reactions. Die zyklischen Terpenoide stellen eine große Gruppe von Naturstoffen mit verschiedensten biologischen Funktionen dar. Bis heute konnten etwa 60. 000 verschiedene zyklische Terpenoide, die aus Gerüsten von zehn bis über 30 Kohlenstoffatomen aufgebaut sind, identifiziert werden. Unter dieser großen Anzahl von zyklischen Stoffen finden sich viele bekannte Duft- und Aromastoffe, wie zum Beispiel Menthol oder Limonen, Verbindungen, die als pharmazeutisch wirksame Inhaltsstoffe in Medikamenten Anwendung finden, wie etwa der gegen Tumor wirksame Stoff Taxol oder das gegen Malaria angewendete Artemisinin oder auch die als Membranbestandteile und Hormone bekannten Steroide. All diese interessanten Naturstoffe werden durch Zyklisierung von wenigen linearen Vorläufermolekülen gebildet. Diese Zyklisierungsreaktionen werden von Terpenoid Zyklasen katalysiert. Der Schwerpunkt der vorliegenden Arbeit liegt auf einer Unterfamilie dieser Enzymgruppe der Terpenoid Zyklasen, den Squalen-Hopen Zyklasen (SHCs). Unter den über 300 annotierten SHCs wurde die SHC vom thermophilen Bakterium Alicyclobacillus acidocaldarius (AacSHC) am besten untersucht. Neben der Kristallstruktur wurde auch der komplexe Mechanismus aufgeklärt, nach dem das lineare C 30 Substrat Squalen zu den pentazyklischen Produkten Hopen und Hopanol zyklisiert wird. Der Mechanismus dieser Reaktion, bei der neun Stereozentren und 13 kovalente C-C Bindungen spezifisch entstehen, gilt als einer der komplexesten, die man in der Chemie der Naturstoffe bislang entdecken konnte. Neben AacSHC wurden in vorangehenden Arbeiten auch einige andere SHCs teilweise charakterisiert. Von besonderem Interesse ist hierbei der gegen hohe Alkohol- und Zuckerkonzentrationen tolerante Stamm Zymomonas mobilis, der als einer der besten Hopanoid-produzierenden Bakterienstämme bekannt ist und zwei Gene enthält, die für SHCs codieren: ZmoSHC 1 und die in vorherigen Arbeiten partiell charakterisierte ZmoSHC 2. Es war gezeigt worden, dass SHCs neben dem natürlichen Substrat Squalen auch einige andere lineare Terpenoide als Substrate akzeptieren und diese zyklisieren. Zum Beispiel konnten verkürzte Squalen-Analoga von AacSHC zyklisiert werden und auch der C 16 -Alkohol Homofarnesol wurde in den entsprechenden zyklischen Ether Ambroxan umgesetzt. Diese Ergebnisse ließen darauf schließen, dass die SHCs eine vielversprechende Enzymfamilie zur Katalyse von sehr verschiedenen, komplexen Zyklisierungsreaktionen darstellen könnten und deswegen entschieden wir uns dazu, die Substratbreite der SHCs näher zu untersuchen. Um die Squalen-Hopen Zyklasen ZmoSHC 1 und ZmoSHC 2 zu charakterisieren und ihre biokatalytischen Aktivitäten mit der von AacSHC vergleichen zu können, wurden die für diese Enzyme codierenden Gene kloniert und heterolog in Escherichia coli exprimiert. Die Expression funktioneller Enzyme wurde durch Umsetzung des natürlichen Substrates Squalen bestätigt. Um die Enzyme direkt miteinander vergleichen zu können, wurde ein Protokoll für die partielle Aufreinigung der membrangebundenen SHCs ausgearbeitet und optimiert. Für diese Aufreinigung sowie für die Umsetzung der hydrophoben Substrate in wässrigem Milieu musste ein geeignetes Detergenz verwendet werden. ZmoSHC 1 wurde des Weiteren näher charakterisiert, wobei die pH- und Temperaturabhängigkeit der katalytischen Aktivität, die biokatalytische Stabilität des Enzyms über eine längere Zeitdauer sowie Inhibierungseffekte untersucht wurden. Die drei Enzyme wurden auf Aktivität gegenüber unnatürlichen Substraten mit C-Kettenlängen von C 10 -C 18 getestet. Ein besonderer Fokus wurde hierbei auf Substrate gelegt, die funktionelle Gruppen enthalten, wie zum Beispiel Hydroxyl-, Carboxy- oder Ketogruppen, die, wie für die Hydroxylgruppe von Homofarnesol gezeigt, an der Zyklisierungsreaktion teilnehmen könnten. Interessanterweise wurden diese funktionellen Gruppen in den finalen Ring der polyzyklischen Produkte integriert, wodurch Produkte mit neuen, attraktiven Eigenschaften entstanden. Homofarnesol konnte in den zyklischen Ether und bekannten Duftstoff Ambroxan umgesetzt werden. Die entsprechende Carbonsäure Homofarnesolsäure wurde ebenfalls als Substrat akzeptiert und es wurde das zyklische Lakton Sclareolid erhalten. Der tertiäre C 15 Alkohol Nerolidol wurde zum bizyklischen Caparrapioxid umgesetzt. Des Weiteren wurden auch zwei Ketone als Substrate akzeptiert und in zyklische Enolether umgesetzt. Im Rahmen der vorliegenden Arbeit wurden die neuen Produkte nach präparativer Biotransformation und Aufreinigung charakterisiert. Nicht nur die Tatsache, dass diese Substrate sehr viel kürzere Kohlenstoff-Ketten als das „natürliche“ Substrat Squalen besitzen und über verschiedene funktionelle Gruppen verfügen, die an den Zyklisierungsreaktionen teilhaben und zu interessanten Produkten umgesetzt werden, sondern auch die unterschiedlichen Aktivitäten der SHCs gegenüber dieser Substrate sind bemerkenswert. Es konnte gezeigt werden, dass ZmoSHC 1 über besondere Eigenschaften verfügt, da unerwartete Umsetzungsraten bei der Katalyse mit diesem Enzym bestimmt wurden. Während die Zyklisierung von Squalen von ZmoSHC 1 nur sehr gering katalysiert wurde, wurde eine gute Aktivität gegenüber der Reaktion von Homofarnesol zu Ambroxan ermittelt. Alle anderen beschriebenen Substrate wurden in geringen, aber signifikanten Raten umgesetzt. Ein vollkommen anderes Aktivitäts-Muster wurde bei Umsetzungen mit AacSHC erhalten. Hier wurde neben sehr guter Umsetzung von Squalen eine viel geringere Aktivität gegenüber allen anderen Substraten bestimmt. Vom Enzym ZmoSHC 2 wurden nur Squalen und Farnesylaceton mit sehr geringer Aktivität als Substrate akzeptiert, alle anderen Substrate wurden nicht umgesetzt. Anhand dieser Ergebnisse kann gefolgert werden, dass SHCs als vielseitige Biokatalysatoren für komplexe Zyklisierungsreaktionen verwendet werden können, da diese Enzyme eine unerwartete Substrataktivität mit anderen Substraten als Squalen zeigen. In der vorliegenden Arbeit werden diese und weitere Ergebnisse im Detail beschrieben. Neben der erwähnten Untersuchung der Aktivität der verschiedenen SHCs gegenüber unterschiedlichen Substraten wurden auch Mutanten hergestellt und untersucht, die zu einer Erklärung der Aktivitätsunterschiede zwischen den verschiedenen Squalen-Hopen Zyklasen verhelfen sollten. Diese Charakterisierung der Triterpen Zyklasen und die Diskussion ihrer besonderen Eigenschaften führen zu neuen Schlussfolgerungen über das Potenzial von SHCs, als fähige Biokatalysatoren für noch nie gezeigte Reaktionen eingesetzt werden zu können...|$|E

